venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 8
- −1 vs. Q2 2022
- Portfolio value
- $432.2M
- +$81.0M (+23.1%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VTYXVentyx Biosciences, Inc. | COM | 5,011,536 | $175.0M | 40.5% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $92.8M | 21.5% | 00.0% | Unchanged | History |
| CINCCinCor Pharma, Inc. | COM | 1,862,256 | $61.1M | 14.1% | −282,779−13.2% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,125,673 | $49.9M | 11.5% | −323,047−22.3% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 596,483 | $20.3M | 4.7% | −1,575,181−72.5% | Reduced | History |
| PHVSPharvaris N.V. | COM | 2,296,710 | $17.6M | 4.1% | −4,741−0.2% | Reduced | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $13.4M | 3.1% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,866,339 | $2.11M | 0.5% | 00.0% | Unchanged | History |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are gone from this filing.